ORCHARD THERAPEUTICS PLC Research and Development Expense
ORCHARD THERAPEUTICS PLC reported Research and Development Expense of $14.55 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC research and development expense for the quarter ending 2023-09-30 was $14.55M, a 19.61% decline year-over-year.
- ORCHARD THERAPEUTICS PLC research and development expense for the quarter ending 2023-06-30 was $16.70M, a 23.99% decline year-over-year.
- ORCHARD THERAPEUTICS PLC research and development expense for the quarter ending 2023-03-31 was $15.99M, a 43.36% decline year-over-year.
- ORCHARD THERAPEUTICS PLC research and development expense for the quarter ending 2022-12-31 was $25.55M, a 9.42% increase year-over-year.
- ORCHARD THERAPEUTICS PLC research and development expense for fiscal 2022 was $93.85M, a 7.90% increase from fiscal 2021.
- ORCHARD THERAPEUTICS PLC research and development expense for fiscal 2021 was $86.98M, a 7.20% decline from fiscal 2020.
- ORCHARD THERAPEUTICS PLC research and development expense for fiscal 2020 was $93.73M, a 20.14% decline from fiscal 2019.
- ORCHARD THERAPEUTICS PLC research and development expense for fiscal 2019 was $117.36M, a 42.84% decline from fiscal 2018.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $14.55M 10-Q · filed 2023-11-13 | $31.25M derived: sum of 2 quarters · filed 2023-11-13 | $47.24M 10-Q · filed 2023-11-13 | $72.79M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $16.70M 10-Q · filed 2023-08-10 | $32.69M 10-Q · filed 2023-08-10 | $58.23M derived: sum of 3 quarters · filed 2023-08-10 | $76.34M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $15.99M 10-Q · filed 2023-05-15 | $41.54M derived: sum of 2 quarters · filed 2023-05-15 | $59.64M derived: sum of 3 quarters · filed 2023-11-13 | $81.61M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $25.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $43.65M derived: sum of 2 quarters · filed 2023-11-13 | $65.61M derived: sum of 3 quarters · filed 2023-11-13 | $93.85M 10-K · filed 2023-03-14 |
| 2022-09-30 | $18.10M 10-Q · filed 2023-11-13 | $40.07M derived: sum of 2 quarters · filed 2023-11-13 | $68.30M 10-Q · filed 2023-11-13 | $91.65M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $21.96M 10-Q · filed 2023-08-10 | $50.20M 10-Q · filed 2023-08-10 | $73.55M derived: sum of 3 quarters · filed 2023-08-10 | $94.39M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $28.23M 10-Q · filed 2023-05-15 | $51.58M derived: sum of 2 quarters · filed 2023-05-15 | $72.43M derived: sum of 3 quarters · filed 2023-05-15 | $94.18M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $23.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $44.19M derived: sum of 2 quarters · filed 2023-03-14 | $65.94M derived: sum of 3 quarters · filed 2023-03-14 | $86.98M 10-K · filed 2023-03-14 |
| 2021-09-30 | $20.85M 10-Q · filed 2022-11-14 | $42.60M derived: sum of 2 quarters · filed 2022-11-14 | $63.63M 10-Q · filed 2022-11-14 | $86.28M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $21.75M 10-Q · filed 2022-08-04 | $42.78M 10-Q · filed 2022-08-04 | $65.43M derived: sum of 3 quarters · filed 2022-08-04 | $80.11M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $21.04M 10-Q · filed 2022-05-12 | $43.68M derived: sum of 2 quarters · filed 2022-05-12 | $58.36M derived: sum of 3 quarters · filed 2022-05-12 | $89.93M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $22.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $37.33M derived: sum of 2 quarters · filed 2022-03-30 | $68.89M derived: sum of 3 quarters · filed 2022-03-30 | $93.73M 10-K · filed 2022-03-30 |
| 2020-09-30 | $14.68M 10-Q · filed 2021-11-04 | $46.25M derived: sum of 2 quarters · filed 2021-11-04 | $71.08M 10-Q · filed 2021-11-04 | $101.98M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $31.57M 10-Q · filed 2021-08-04 | $56.40M 10-Q · filed 2021-08-04 | $87.30M derived: sum of 3 quarters · filed 2021-08-04 | $115.80M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $24.84M 10-Q · filed 2021-05-13 | $55.73M derived: sum of 2 quarters · filed 2021-05-13 | $84.23M derived: sum of 3 quarters · filed 2021-05-13 | $124.71M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $30.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $59.39M derived: sum of 2 quarters · filed 2021-03-02 | $99.87M derived: sum of 3 quarters · filed 2021-03-02 | $117.36M 10-K · filed 2021-03-02 |
| 2019-09-30 | $28.49M 10-Q · filed 2020-11-03 | $68.97M derived: sum of 2 quarters · filed 2020-11-03 | $86.46M 10-Q · filed 2020-11-03 | $103.89M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $40.48M 10-Q · filed 2020-08-06 | $57.97M 10-Q · filed 2020-08-06 | $75.40M derived: sum of 3 quarters · filed 2020-08-06 | $103.13M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $17.49M 10-Q · filed 2020-05-07 | $34.92M derived: sum of 2 quarters · filed 2020-05-07 | $62.65M derived: sum of 3 quarters · filed 2020-05-07 | $213.64M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $17.43M derived: 10-K 12 month − 6-K 9 month · filed 2020-02-27 | $45.16M derived: sum of 2 quarters · filed 2020-02-27 | $196.15M derived: sum of 3 quarters · filed 2020-02-27 | $205.32M 10-K · filed 2020-02-27 |
| 2018-09-30 | $27.73M 6-K · filed 2019-11-07 | $178.72M derived: sum of 2 quarters · filed 2019-11-07 | $187.89M 6-K · filed 2019-11-07 | |
| 2018-06-30 | $150.99M 6-K · filed 2019-08-08 | $160.16M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | $9.17M 6-K · filed 2019-05-28 | |||
| 2017-12-31 | $32.53M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $16.21M 20-F · filed 2019-03-22 |